A case of small well-differentiated hepatocellular carcinoma with marked lymphocytic infiltrate.

HCV Lymphocytic infiltration small HCC well-differentiated HCC

Journal

International journal of clinical and experimental pathology
ISSN: 1936-2625
Titre abrégé: Int J Clin Exp Pathol
Pays: United States
ID NLM: 101480565

Informations de publication

Date de publication:
2020
Historique:
received: 10 01 2020
accepted: 07 02 2020
entrez: 10 4 2020
pubmed: 10 4 2020
medline: 10 4 2020
Statut: epublish

Résumé

We herein report a case of well-differentiated small hepatocellular carcinoma (HCC) with severe lymphocytic infiltrate (SLI) in a 55-year-old male patient with HCV-related cirrhosis. The patient had been followed-up because of HCV-related cirrhosis. He was found to have two small nodules in S8 by imaging techniques, and he underwent S8 segmentectomy. The resected liver showed two small nodules. Both were encapsulated, well-defined, solid, reddish and expansive nodules with fibrous septa. They measured 8 × 8 mm and 15 × 10 mm, respectively. Histologically, both tumours were pure HCC; the smaller showed SLI with lymphocytes/HCC cells ratio over 20, while the larger showed mild lymphocytic infiltration with lymphocytes/HCC cells ratio of 0.8. The smaller HCC was well-differentiated (trabecular thickness <3) HCC-SLI with Edmondson II = I cytologic atypia, while the larger was moderately-differentiated (trabeculae >3) HCC (Edmondson II>III>I). Extremely well-differentiated Edmondson I HCC or adenomatous hyperplasia areas were seen in the periphery of both HCCs. The patterns of SLI could be classified into the following three: sinusoids (S) type, portal tract (PT) type, lymph follicle (LF) type. In S-type, lymphocytes were infiltrated between the trabeculae. In PT-type, SLI was found to arise from extension from already inflamed PT within HCC or neighboring PT. The HCC cells frequently exhibited moth-eaten or piece meal necrosis in PT-type. In LF-type, lymphocytes were activated, and nuclear dusts were noted. It appeared that LF-type has arisen from preexisting S-type and/or PT-type. We speculated that the entry of SLI was from S in S-type, from incorporated inflamed PT in PT-type, and from both in LF-type. The approximate overall positive ratios of lymphoid cells among inflammatory cells were as follows: CD20 50%, CD3 70%, CD4 50%, CD8 30%, CD138 3%, CD163 40%, granzyme B 2%, smooth muscle actin (SMA) 30%, CD31 30%, CD21 2%, S100 3%, bcl-2 10%, CK19 1%, CD10 1%, CD30 0%, CD56 0% and Ki67 labeling index = 5%. EBV-ISH and HPV IHC were negative. Interestingly, Kupffer cells had myofibroblastic antigen in addition to macrophage antigens, and stellate cells expressed macrophage antigens aside from myofibroblastic antigens. These data suggest that, in the present case, pan-B-cells, pan-T-cells, helper T-cells, cytotoxic T-cells, plasma cells, macrophages, Kupffer cells, stellate cells, myofibroblasts, fibroblasts, endothelial cells, dendritic cells, Langerhans cells, and toxic molecules may play roles in tumour immunology.

Identifiants

pubmed: 32269704
pmc: PMC7137018

Types de publication

Case Reports

Langues

eng

Pagination

624-633

Informations de copyright

IJCEP Copyright © 2020.

Déclaration de conflit d'intérêts

None.

Références

World J Gastrointest Oncol. 2011 Jul 15;3(7):111-5
pubmed: 21860687
Am J Pathol. 1993 Jul;143(1):105-20
pubmed: 7686339
Pathol Res Pract. 2009;205(9):648-52
pubmed: 19217218
Semin Liver Dis. 2010 Aug;30(3):245-57
pubmed: 20665377
Int J Clin Exp Med. 2013;6(3):219-26
pubmed: 23573354
Mod Pathol. 1995 May;8(4):371-9
pubmed: 7567933
Clin Exp Immunol. 1991 May;84(2):303-7
pubmed: 2025957
World J Gastroenterol. 2008 Aug 7;14(29):4694-6
pubmed: 18698686
Int J Clin Exp Pathol. 2015 Mar 01;8(3):3282-7
pubmed: 26045853
Gastroenterology. 1990 Jul;99(1):200-10
pubmed: 2344926
Hepatology. 1997 Aug;26(2):407-15
pubmed: 9252152
Cancer. 1993 Sep 1;72(5):1551-6
pubmed: 8394196
Hum Pathol. 1991 May;22(5):486-93
pubmed: 1851720
Nat Immunol. 2013 Oct;14(10):986-95
pubmed: 24048120
World J Gastroenterol. 2015 Mar 28;21(12):3472-9
pubmed: 25834311
Virchows Arch A Pathol Anat Histopathol. 1989;415(1):61-7
pubmed: 2499979
Am J Surg Pathol. 2015 Mar;39(3):304-12
pubmed: 25675010
World J Surg Oncol. 2013 May 04;11:97
pubmed: 23642182
Am J Surg Pathol. 2001 Nov;25(11):1464-6
pubmed: 11684969
Virchows Arch A Pathol Anat Histopathol. 1989;415(2):131-6
pubmed: 2500768
Histopathology. 2001 Nov;39(5):540
pubmed: 11737314
World J Gastroenterol. 2015 Sep 28;21(36):10468-74
pubmed: 26420974
Hepatology. 1998 Feb;27(2):407-14
pubmed: 9462638
Hepatology. 1993 Sep;18(3):529-36
pubmed: 8359795
Virchows Arch A Pathol Anat Histopathol. 1993;422(5):381-8
pubmed: 8391735
Cancer. 1954 May;7(3):462-503
pubmed: 13160935
Cancer. 1992 Aug 1;70(3):591-8
pubmed: 1352480
Liver. 1989 Jun;9(3):172-8
pubmed: 2545998
Am J Surg Pathol. 2001 Apr;25(4):516-20
pubmed: 11257627
Am J Pathol. 2017 Jul;187(7):1438-1444
pubmed: 28500863
Arch Pathol Lab Med. 2014 Sep;138(9):1193-202
pubmed: 25171701
Arch Pathol Lab Med. 1991 Oct;115(10):993-7
pubmed: 1898247
Arch Pathol Lab Med. 1989 Aug;113(8):916-20
pubmed: 2757493
J Hepatol. 1996 Jun;24(6):706-12
pubmed: 8835746
Int J Surg Pathol. 2000 Oct;8(4):347-351
pubmed: 11494016
Virchows Arch. 1995;427(4):379-83
pubmed: 8548122
Case Rep Oncol. 2011 Feb 14;4(1):68-73
pubmed: 21475593
Leuk Lymphoma. 2002 Jul;43(7):1497-500
pubmed: 12389636
J Hepatol. 1989 Mar;8(2):139-49
pubmed: 2541196
Indian J Pathol Microbiol. 2015 Oct-Dec;58(4):550-3
pubmed: 26549091
Arch Pathol Lab Med. 1991 Jan;115(1):50-5
pubmed: 1846286
Nat Immunol. 2012 Nov;13(11):1072-82
pubmed: 22983360
Gastroenterology. 1987 Nov;93(5):1078-85
pubmed: 3308622
Hum Pathol. 1996 Aug;27(8):848-50
pubmed: 8760021
Histopathology. 1995 Oct;27(4):333-9
pubmed: 8847063
Ann Hepatol. 2017 Jan-Feb 2017;16(1):157-159
pubmed: 28051805
Histopathology. 2000 Dec;37(6):523-9
pubmed: 11122434

Auteurs

Tomohiro Iwasaki (T)

Department of Pathology, Shizuoka General Hospital No. 4-27-1, Kita-Ando, Aoi-ku, Shizuoka, Shizuoka 420-8527, Japan.

Aki Kubota (A)

Department of Pathology, Shizuoka General Hospital No. 4-27-1, Kita-Ando, Aoi-ku, Shizuoka, Shizuoka 420-8527, Japan.

Makoto Suzuki (M)

Department of Pathology, Shizuoka General Hospital No. 4-27-1, Kita-Ando, Aoi-ku, Shizuoka, Shizuoka 420-8527, Japan.

Tadashi Terada (T)

Department of Pathology, Shizuoka General Hospital No. 4-27-1, Kita-Ando, Aoi-ku, Shizuoka, Shizuoka 420-8527, Japan.

Classifications MeSH